DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Fasching PA, Loibl S, Hu C. et al.
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
J Clin Oncol 2018;
DOI: 10.1200/JCO.2017.77.2285.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.